viral vectors

Kite
Manufacturing

With ‘lessons learned,’ Kite preps for key CAR-T launch

Gilead's Kite is preparing to hit the ground running with the potential approval of a next-generation multiple myeloma cell therapy later this year.
Fraiser Kansteiner Apr 28, 2026 11:30am
Three blocks displaying from left to right a person a handshake and another person

OXB expands BMS partnership for CAR-T lentiviral vectors

Feb 4, 2026 10:25am
FDA

FDA restricts bluebird's gene therapy after blood cancer reports

Aug 8, 2025 11:19am
FDA

FDA investigates 2 deaths after Sarepta Duchenne gene therapy

Jun 25, 2025 10:26am
Redbrick building with Sarepta name and logo

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Jun 16, 2025 10:58am
Bristol Myers Squibb

BMS calls it quits on vector production at former Novartis plant

May 2, 2025 11:20am